⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight
globenewswire.com
IMVT
ROIV
CART
NVS
MRK
REGN
UCB
JNJ
AMGN
ARGX
KYMR
CABA
BMY
BHVN
Sport Beach is Back for Cannes 2026
accessnewswire.com
ADBE
PEP
EA
TTD
Z
TROW
AMZN
DDOG
F
GOOG
INTC
META
NFLX
NVDA
SPOT
STX
TSLA
CRM
SPGI
MSFT
GOOGL
FDX
CMCSA
DIS
AAPL
IBM
GE
BA
GS
JPM
BAC
WMT
COST
TGT
BABA
JD
PDD
ETSY
EBAY
PYPL
COIN
HOOD
UPST
SOFI
PLTR
SNOW
CRWD
PANW
ZS
FTNT
DD
DOW
LMT
GD
RTX
CAT
DE
AGCO
CNH
HON
MMM
XOM
CVX
SHEL
T
VZ
TMUS
LYFT
UBER
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
NVS
AZN
BIIB
REGN
VRTX
MDLZ
KHC
CL
PG
BANC
Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab
prnewswire.com
GSK
BIIB
LLY
MRK
TAK
ALNY
BMY
NVS
REGN
VRTX
Francois Schramek Promoted to Partner at Manhattan West
prnewswire.com
AI
AMN
GM
LMT
NVDA
GOOG
MSFT
SPCE
RKLB
GD
BA
AMD
INTC
META
CRWD
PLTR
AN
DD
HON
RTX
IBM
AMZN
TSLA
XOM
CVX
UNH
BMY
PFE
MRK
JNJ
LLY
GILD
REGN
BIIB
AMGN
AZN
NVO
SNY
TEVA
BABA
JD
NTES
BIDU
IQ
VIPS
BZUN
HTHT
MELI
BBD
BB
ERIC
NOK
QCOM
MU
ADSK
CRM
GOOGL
Telix and Regeneron Announce Strategic Radiopharma Collaboration
globenewswire.com
REGN
TLX
Regeneron and Telix Announce Strategic Radiopharma Collaboration
globenewswire.com
REGN
TLX
Follicular Lymphoma Market Insight, Epidemiology, and Forecasts, 2022-2026 & 2026-2036
globenewswire.com
AZN
GILD
ABBV
REGN
BIIB
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
globenewswire.com
SNY
REGN
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
globenewswire.com
REGN
SNY
7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments
globenewswire.com
ABBV
GSK
AZN
GILD
REGN